TokenPost·
FDA Approves Inovio’s VOCERYQ to Reduce RRP Surgery Frequency
In a 32-person study, seven of 26 patients in the efficacy group had no surgical excision during the 12 months after treatment.
More news
- TokenPostOKX Scheduled Five Stock Perpetuals to Open in 15-Minute Steps
- TokenPostCramer’s Charitable Trust Plans 40-Share Boeing Purchase After 10% Drop
- TokenPostOpenAI Plans to Merge ChatGPT’s Chat and Work Tabs for Users
- Crypto BriefingAnthropic’s amended IPO filing warns its models may soon hit a key AI progress threshold
- DecryptBitmine Buys More Ethereum as Tom Lee Calls the Binance Hack Bullish
- Crypto BriefingSecuritize brings Arista, ExxonMobil, Uber and Disney shares to Solana